当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Carlo Petruzzellis, Sebastian Manuel Milluzzo, Nicola Petruzzellis, Pietro Cesari
Introduction: Metabolic syndrome (MS) is considered a possible risk factor for CRC, also because it affects bowel cleansing. As primary aim, association between MS or each parameter of MS and the prevalence and histology of precancerous colonic lesions (PCL) was examined. The secondary aim was to analyze the impact of these on bowel cleansing. precancerous colonic lesions (PCL) were examined.
Methods: In this observational single-center study, all consecutive outpatients, who underwent colonoscopy from May to September 2014, were enrolled. For statistical analysis, patients were collapsed into two groups according to the presence or absence of MS.
Results: 1257 patients were enrolled. MS was a risk factor for serrated lesions in the left colon (3% vs 1.2%; p=0.049). Analyzing MS parameters, only a higher BMI was associated with an increased risk of having an adenoma overall (25% for BMI >30), for colonic lesions in the left colon (RR 30%; p<0.01) and only for adenoma in the right colon (RR 30%; p<0.05). MS was inversely related with bowel cleansing overall and per-segments.
Conclusion: The presence of MS and obesity should be taken into consideration prescribing bowel preparation regimen and also for post-polypectomy surveillance, as these elements should be considered as aggravating cancer risk.